MMMoncef Mokni

Moncef Mokni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Moncef Mokni has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correlation of epigenetic markers with glioblastoma patients’ survival and molecular subtypes: insights from methylation-specific MLPA analysis

    by Saoussen Trabelsi, Abdelbasset Amara, Imen Chabchoub, Mohamed Ladib, Hedi Krifa, Nadia Mama, Kalthoum Tlili, Moncef Mokni, Mohamed Tahar Yaacoubi, Chris Jones, et al.

    Objectives: Glioblastoma (GB) is a heterogeneous group of tumors with poor patient’s outcome. The epigenetic markers could influence patient’s outcome and add more precision in sub-typing. Methods: The study aims to determine a correlation between the methylation status of 65 genes and the overall survival (OS) in 50 GB Tunisian patients using methylation specific-multiplex ligation-dependent probe amplification (MS-MLPA) technique. Results: OS was significantly longer for patients with tumors harboring unmethylated tumor suppressor genes ATM , BRCA1 , BRCA2 , TP53 and TP73 and the DNA repairing gene MSH6 . Furthermore, simultaneous unmethylation of ATM , BRCA2 , CD44 and VHL genes was associated with GB presenting normal EGFR status. This subgroup exhibits a better prognosis (OS=15 months, p=0.005). Our results also showed that, combined methylation of TP73 , THBS1 , GSTP1 and ESR1 genes in amplified EGFR GB subtype resulted in a poor prognosis group (OS=3 months, p=0.041). Simultaneous methylation of HLTF and SFRP5 genes was associated with wild-type IDH1 GB defining therefore a very poor prognosis group (OS=1 month, p=0.026). Besides, BRCA1 methylation in wild-type IDH1 group was significantly associated with poor prognosis (OS=6 months, p=0.002). Interestingly, RBM14 and PCCA genes were co-methylated in 80 % of prolonged survival cases (GB+). In absence of EGFR amplification and with unmethylation of BRCA1 , BRCA2 , ATM , VHL , CD44 , HLTF and SFRP5 genes, GB+ tumors seemed to respond better to treatment, avoiding the relapse and conferring prolonged survival (>36 months). Conclusions: Combining genes methylation status of GB with EGFR and IDH1 profiles will refine subtyping, predict patient’s outcomes and guide personalized therapy.

  • Open Access

    Isolated Hydatid Cyst of the Breast: A Rare Pseudotumor of the Breast

    by Badra Bannour, Mariem Romdhani, Dorra Chiba, Imen Bannour, Atef Ben Abdelkader, Moncef Mokni, Sassi Boughizane

    Isolated Hydatid Cyst of the Breast: A Rare Pseudotumor of the Breast - European Journal of Breast Health


  • Open Access

    From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis

    by Hafedh Abbassi, Badra Bannour, Sarra Yacoub, Ekram Guerbej, Imen Bannour, Samir Hidar, Moncef Mokni

    From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis - European Journal of Breast Health


  • Clinicopathological and prognostic significance of DNA mismatch-repair protein expression in gastric adenocarcinoma

    by Nabiha Missaoui, Nozha Mhamdi, Hanene Saad, Ahlem Bdioui, Nihed Abdessayed, Atef Ben Abdelkader, Thouraya Zahmoul, Hajer Hamchi, Sihem Hmissa, Moncef Mokni

    Although the significance of DNA mismatch repair (MMR) protein expression in colorectal cancer is well-established, it remains contentious in extra-colorectal cancers and mainly in gastric adenocarcinoma. Data from Africa and Arab world remain limited. This study explored the MMR expression in gastric adenocarcinoma and evaluated its clinicopathological and prognostic signification among Tunisian patients. A retrospective study of 72 gastric adenocarcinomas was carried out. Clinicopathological particularities and patient outcomes were recorded. MMR expression was determined by immunohistochemistry on whole sections of archived material. Survival analysis was realized utilizing the Kaplan-Meier estimates and Log-Rank test. Expression of MMR proteins was observed in 84.7% of gastric adenocarcinoma samples. The 11 remaining samples (15.3%) exhibited an altered pattern of MMR protein. A significant association was identified between deficient MMR expression and advanced age (p = 0.03), intestinal type (p = 0.04) and lymph node metastases (p = 0.04). No other significant relationship was observed with the remaining selected tumor features. Patient survival was significantly associated with lymph node invasion (p = 0.002), distant metastases (p = 0.02) and tumor differentiation (p = 0.03), but not with MMR status (p = 0.83). MMR deficiency was related to advanced-age, intestinal type and nodal metastasis, but not to survival of Tunisian patients with gastric adenocarcinoma. Larger multicenter studies with additional molecular investigation are required to more explore these tumors.


  • Open Access

    Mitotically active fibrothecoma in association with sclerous peritonitis

    by Ahlem Bdioui, Sarra Ben Khlifa, Ons Kaabia, Nabiha Missaoui, Sihem Hmissa, Moncef Mokni

    Mitotically active fibrothecoma associated with sclerosing peritonitis is an enigmatic and rare condition, described by Clement et al. in 1994, with fewer than 50 pathologically characterized cases. Association of these two lesions is extremely rare and the etiology currently remains unclear; therefore, association with anti-epileptic drugs was suggested.

  • Open Access

    Primary Seminal Vesicle Adenocarcinoma Presenting as Acute Urinary Retention and Hematuria: A Case Report

    by Khaireddine Bouassida, Wissem Hmida, Sarra Mestiri, Ghassen Tlili, Moncef Mokni, Ali Tahar Mosbah

    Primary tumors of the seminal vesicle are extremely rare lesions, and adenocarcinoma is the most common histology found. We report the case of a 54-year-old patient who has consulted with a bladder outlet obstruction and two episodes of initial hematuria for 3 months. Digital rectal examination revealed a hard, palpable mass in the prostate wall. The prostate-specific antigen (PSA), the serum carcinoembryonic antigen and the cancer antigen 125 (CA125) were normal. On imaging, a prostatic abscess, granulomatous prostatitis or a prostatic cancer were highly suspected at first. But the patient was afebrile and PSA was normal. Transrectal ultrasound-guided biopsies of the mass were performed. The pathological examination showed a poorly differentiated adenocarcinoma. Immunohistological analysis was strongly suggestive of adenocarcinoma of the seminal vesicle. At surgical exploration, it was impossible to make cystoprostato-vesiculectomy because the tumor was locally advanced. We decided to make hormonal blockage by antiandrogen and five sessions of radiotherapy. Unfortunately, the patient died 5 months later. Adenocarcinoma of the seminal vesicles is a rare diagnosis. We must think in this diagnosis when relatively young patient is presented with dysuria, hematuria or hemospermia and when we found hard palpable mass on digital rectal examination associated to normal PSA level. On histology, specific immunohistochemical markers would be helpful in this differential diagnosis. Actually, surgical excision is the mainstay of the treatment. Radiotherapy and androgen deprivation therapy can be an alternative in locally advanced and metastatic carcinomas. World J Nephrol Urol. 2015;4(3):242-246 doi: http://dx.doi.org/10.14740/wjnu204e


  • Open Access

    Growing Teratoma Syndrome After Treatment of a Nonseminomatous Germ Cell Tumor: A Case Report and a Review of Literature

    by W. Boukettaya, M. Hochlaf, Z. Boudagga, F. Ezzairi, I. Chabchoub, O. Gharbi, L. Ben Fatma, B. Sriha, M. Mokni, C.H. Kraim, et al.


  • Open Access

    Editorial Board

    by Selma Ugurel, Hossein Khedmat, Alan Horwich, Pierluigi Brugnaro, Erika Morelli, Marta Fiscon, Francesca Ebo, Giorgio Rosini, Fabio Belussi, Franklyn Eseme, et al.


  • Prévalence des infections à papillomavirus (HPV) dans les lésions précancéreuses et cancéreuses du col utérin en Tunisie

    by Nahiba Missaoui, Sihem Hmissa, Amel Trabelsi, Mohamed Tahar Yacoubi, Amel Nouira, Lucien Frappart, Moncef Mokni, Sadok Korbi

    To investigate the distribution of HPV genotypes inuterine cervical lesions in Central Tunisia in order to predict the impact ofHPV vaccines and HPV-based screening tests among Tunisian women. We performed a retrospective study of 146 fixed tissues including 30 benign lesions, 36 low-grade cervical intraepithelial neoplasias (CIN1), 45 high-grade cervical intraepithelial neoplasias (CIN2/3), 26 invasive squamous cell carcinomas (SCC) and 9 adenocarcinomas. HPV infection detection and typing were investigated by PCR technique using consensus GP5/GP6 primers and type specific primers for HPV6/11, 16, 18, 31 and 33. Among our patients, overall HPV prevalence was 73.6% (p = 0.0001). HPV infection was associated to 84% of precancerous lesions and 83.9% of cancers. High-risk HPV infection (HPV16 and 18) was detected in 17.4% of CIN1, 74.3% of CIN2/3 (p = 0.002) and 73.1% of cancers (p = 0.001). HPV16 was the most common type among CIN2/3 (51.2%, p < 0.001), invasive SCC (47.6%, p = 0.001) and adenocarcinomas (80%, p < 0.001). This study supports previous population-based studies in which similar HPV detection rates were found among random samples of women. HPV-based screening tests and HPV vaccination would be efficient in uterine cervix cancer prevention among women in the Central Tunisia.